Long‐term efficacy and safety of stapokibart for moderate‐to‐severe atopic dermatitis: 52‐week results from a phase 3 trial

Long-term treatment with stapokibart demonstrated a sustained efficacy and favorable safety profile in adults with moderate-to-severe AD.

Authors

Institutions

Publication Details

Journal
Allergy
Published
2024-10-25
DOI
https://doi.org/10.1111/all.16368
Citations
20
Primary Topic
Dermatology and Skin Diseases
Type
article
Field-Weighted Citation Impact
10.69
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Long‐term efficacy and safety of stapokibart for moderate‐to‐severe atopic dermatitis: 52‐week results from a phase 3 trial

Yan Zhao, Qing Sun, Chao Ji, Bin Yang et al.
20 citations
Allergy
Dermatology and Skin Diseases
10.69
article

Long‐term efficacy and safety of stapokibart for moderate‐to‐severe atopic dermatitis: 52‐week results from a phase 3 trial

Yan Zhao, Qing Sun, Chao Ji, Bin Yang, Qingchun Diao, Xiaohua Tao, Tao Cai, Rong Xiao, Qianjin Lu, Fuqiu Li, Liming Wu, Xiao‐Yong Man, Lihua Wang, Linfeng Li, Jianzhong Zhang, Yumei Li, Jinyan Wang, Xiaohong Zhu, Yanyan Feng, Litao Zhang, Hong Ren, Jianyun Lu, Jingyi Li, Huiming Zeng
article en
20 citations

Abstract

Long-term treatment with stapokibart demonstrated a sustained efficacy and favorable safety profile in adults with moderate-to-severe AD.

AllergyVol. 80(5)
Jiangnan University (CN), Jiangsu University (CN), Tianjin University of Traditional Chinese Medicine (CN), Fujian Medical University (CN), Central South University (CN), Capital Medical University (CN), Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Peking University (CN), Sichuan University (CN), Westlake University (CN), West China Hospital of Sichuan University (CN), Ningbo No. 2 Hospital (CN), Jinan Central Hospital (CN), Chinese Academy of Medical Sciences Dermatology Hospital (CN), Affiliated Hospital of Jiangsu University (CN), First Affiliated Hospital of Fujian Medical University (CN), Peking University People's Hospital (CN), Wuxi No.2 People's Hospital (CN), The First People’s Hospital of Lianyungang (CN), The Affiliated Yongchuan Hospital of Chongqing Medical University (CN), Zhejiang Provincial People's Hospital (CN), Chengdu Second People's Hospital (CN), Second Affiliated Hospital of Jilin University (CN), Beijing Friendship Hospital (CN), Affiliated Hangzhou First People's Hospital, Westlake University, School of Medicine (CN), Second Xiangya Hospital of Central South University (CN), Third Xiangya Hospital (CN), Second Affiliated Hospital of Zhejiang University (CN), Qilu Hospital of Shandong University (CN), First People's Hospital of Chongqing (CN), Shandong First Medical University (CN), Southern Medical University (CN), Hainan Medical University (CN), Chongqing Medical University (CN)
Good health and well-being
Openalex Percentile: Top 1%
Dermatology and Skin Diseases
10.69
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.